[Percutaneous transluminal coronary angioplasty (PTCA) with paclitaxel-coated drug-eluting balloon (DEB). Update 2013]
Hintringer K, Warmuth M
Record ID 32013000923
German
Authors' objectives:
This systematic review is the update of the systematic review 'Medikamentenbeschichteter Ballonkatheter' compiled in 2009 and aims to assess the efficacy and safety of percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB) compared to PTCA with uncoated balloon (UCB) or implantation of a drug-eluting stent (DES) for the treatment of instent restenosis (ISR), small coronary vessel disease (SVD), ostium stenosis and de-novo lesions of coronary vessels.
Authors' recommendations:
Currently, the inclusion of PTCA with DEB into the hospital benefit catalogue is not recommended. The available evidence is insufficient to assess the efficacy and safety of PTCA with DEB in comparison to PTCA with UCB or DES implantation. We recommend a re-evaluation in 2016.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://eprints.hta.lbg.ac.at/1007
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Austria
MeSH Terms
- Angioplasty, Balloon, Coronary
- Paclitaxel
Contact
Organisation Name:
Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address:
Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name:
tarquin.mittermayr@aihta.at
Contact Email:
office@aihta.at
Copyright:
Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.